Veradigm stock: Security portfolio earns HITRUST certification
Published on 10/30/2026 at 02:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSSecurity certification expands Veradigm's assurance profile
- Veradigm said an independent assessment confirmed security controls across a broad set of healthcare technology solutions.
- The certified portfolio spans electronic health records, practice management, payer analytics, and revenue-cycle products.
- The certification provides customers and partners with a standardized assurance signal for security reviews.
Veradigm announced on October 21, 2026, that a broad set of its healthcare technology solutions had achieved HITRUST i1 Certification. The company described the certification as an independently assessed validation of security controls; the announcement was reported by Business Wire.
Independent validation across core products
HITRUST i1 is a threshold-based assessment built around current security practices. According to Veradigm, earning the certification required the relevant controls to be implemented, operational, and verified through an independent assessment rather than self-attestation.
The certified solutions include Veradigm EHR, Veradigm Practice Management, Practice Fusion, Veradigm ePrescribe, Payerpath, FollowMyHealth, Transaction Hub, and several eChart, payer, quality, and revenue-cycle offerings. The breadth of the portfolio gives the announcement relevance beyond a single product line.
Why the announcement matters
For healthcare technology providers, independently validated security controls can reduce uncertainty during customer and partner reviews. Veradigm said the certification offers a standardized assurance signal for clients and prospective clients handling sensitive healthcare data.
The announcement does not by itself quantify revenue, margins, customer additions, or near-term cash-flow effects. Its investor relevance is therefore mainly strategic: stronger compliance credentials may help support trust in a market where data protection is an important purchasing consideration.
Veradigm company facts
- Company: Veradigm
- ISIN: US01988P1084
- Ticker: MDRX
- Trading venue: OTC market
- Sector focus: Healthcare data, clinical, and revenue-cycle solutions
Healthcare investors are also assessing broader cybersecurity and software-sector developments through the S&P 500 market environment.
For further company-specific coverage, see More news and analyses on Veradigm stock.
